• 1
    Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:25602572.
  • 2
    Bakris GL. An approach to achieving recommended blood pressure goals in diabetic patients. Arch Intern Med. 2001;161:26612667.
  • 3
    Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benzazeprilHCl versus comparable component-based therapy. Chem Herit. 2003;9:324332.
  • 4
    Jamerson K, Weber MA, Bakris GL, et al.; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008 ;359:24172428
  • 5
    Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol. 1985;7(suppl 1):S22S55.
  • 6
    Cappuccio FP, Markandu ND, Tucker FA, et al. Does a diuretic cause a further fall in blood pressure in hypertensive patients already on nifedipine? J Clin Hypertens. 1986;4:346353.
  • 7
    Soininen K, Gerlin-Piira L, Suihkonen J, et al. A study of the effects of lisinopril when used in addition to atenolol. J Hum Hypertens. 1992;6:321324.
  • 8
    Huttunen M, Lampainen E, Lilja M, et al. Which anti-hypertensive to add to a beta-blocker: ACE inhibitor or diuretic? J Hum Hypertens. 1992;6:121125.
  • 9
    Bursztyn M, Gavras I, Gourley L, et al. Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazepril. Clin Ther. 1994;16:429436.
  • 10
    Wing LM, Chalmers JP, West MJ, et al. Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions. J Hypertens. 1987;5:S603S606.
  • 11
    Drayer JIM, Weber MA, Lipson JL, et al. Differential effects of diuresis and betaadrenoreceptor blockade during angiotensin converting enzyme inhibition in patients with severe hypertension. J Clin Pharmacol. 1982;22:179186.
  • 12
    Staessen J, Fagard R, Lijnen P, et al. Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients. Am Heart J. 1983;106:321328.
  • 13
    Ruddy MC, Bialy GB, Kostis JB. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation. Angiology. 1989;40:4550.
  • 14
    Wright JT Jr, Bakris GL, Bell DS, et al. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial. J Clin Hypertens (Greenwich). 2007;9:842849.
  • 15
    Hung HM, Chi GYH, Lipicky RJ. Testing for the existence of a desirable dose combination. Biometrics. 1993;49:8594.
  • 16
    Weber MA, Bakris GL, Tarka EA, et al. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension. J Clin Hypertens (Greenwich). 2006;8:840849.
  • 17
    Weber MA, Sica DA, Tarka EA, et al. Controlled-release carvedilol in the treatment of essential hypertension. Am J Cardiol. 2006;7A:32L38L.
  • 18
    Miller A, Reichek N, St. John Sutton M, et al. Late-breaking abstracts presented at the ASH 24th Annual Scientific Meeting and Exposition, May 6–9, 2009, San Francisco, CA. Comparable blood pressure control and LV mass reduction in patients with hypertension and LVH with ACE inhibitor alone or combined with B-blockade. J Clin Hypertens. 2009;11:396.